Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndrome

[1]  Darlyne G. Nemeth,et al.  Understanding the neuropsychological effects of 3q29 deletion Syndrome: A fraternal twin case study , 2020, Applied neuropsychology. Child.

[2]  E. Walker,et al.  Comprehensive phenotyping of neuropsychiatric traits in a multiplex 3q29 deletion family: a case report , 2020, BMC Psychiatry.

[3]  P. Sullivan,et al.  Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature , 2020, Translational Psychiatry.

[4]  Anna Frengen,et al.  Neuropsychiatric phenotype in relation to gene variants in the hemizygous allele in 3q29 deletion carriers: A case series , 2019, Molecular genetics & genomic medicine.

[5]  M. Epstein,et al.  Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry , 2019, Molecular Autism.

[6]  M. Puiu,et al.  A Novel 3q29 Deletion in Association With Developmental Delay and Heart Malformation—Case Report With Literature Review , 2019, Front. Pediatr..

[7]  Wahab A. Khan,et al.  Familial inheritance of the 3q29 microdeletion syndrome: case report and review , 2019, BMC Medical Genomics.

[8]  J. Rosenfeld,et al.  Novel features of 3q29 deletion syndrome: Results from the 3q29 registry , 2016, American journal of medical genetics. Part A.

[9]  M. Butler,et al.  A clinical case report and literature review of the 3q29 microdeletion syndrome , 2015, Clinical dysmorphology.

[10]  J. Mulle.  The 3q29 deletion confers >40-fold increase in risk for schizophrenia , 2015, Molecular Psychiatry.

[11]  Stephen J. Guter,et al.  Co‐occurrence of autism, childhood psychosis, and intellectual disability associated with a de novo 3q29 microdeletion , 2013, American journal of medical genetics. Part A.

[12]  R. Deshaies,et al.  NEDD8 links Cullin–Ring ubiquitin Ligase function to the p97 pathway , 2012, Nature Structural &Molecular Biology.

[13]  S. Leib,et al.  Association of kynurenine aminotransferase II gene C401T polymorphism with immune response in patients with meningitis , 2011, BMC Medical Genetics.

[14]  J. Cummings,et al.  The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment , 2005, Journal of the American Geriatrics Society.

[15]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[16]  Charles D. Smith,et al.  APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD) , 2007, Genetics in Medicine.

[17]  D. Wechsler.  WAIS-R manual : Wechsler adult intelligence scale-revised , 1981 .